The BactiVac Network Catalyst Funding

Dear Colleague

The MRC-supported Bacterial Vaccines (BactiVac) Network, hosted at the University of Birmingham and led by Prof Cal MacLennan and Prof Adam Cunningham, was launched in August 2017 and has a vision to facilitate human and animal bacterial vaccine development focusing on low and middle-income countries (LMICs). Our community of experts from multiple disciplines provides a forum to work together to overcome the barriers that inhibit the delivery of new vaccines where they are most needed.

Our first round of catalyst funding for pump priming projects and training awards was launched on 26th February 2018 at BactiVac’s Inaugural Meeting.  Catalyst funding is available to support scientists in bacterial vaccinology to explore new approaches and strategies to advance their vaccines in partnership with LMICs and across the academia/industry divide. Applications close on Sunday 22 April 2018, 12am midnight (GMT) and you can find out more information about the funding available in this call on our website:

·       BactiVac Catalyst Pump Priming Projects

·       BactiVac Catalyst Training Awards

                                                                                                              

Membership of the BactiVac Network is a prerequisite when applying for these funds, with at least one member of the partnership being based in the UK (for free membership apply here). The key benefits of becoming a member include:

Access to catalyst funding to pump prime projects and facilitate training visits

Invitation to annual meetings where registration costs will be subsidised by the network to encourage members to attend. Travel bursaries are also available to facilitate attendance by members based in LMICs.

 

We look forward to receiving applications for BactiVac catalyst funding from members of our Network.  In the meantime, if you have any queries, please contact us on: BactiVac@contacts.bham.ac.uk

Link: https://www.birmingham.ac.uk/research/activity/immunology-immunotherapy/research/bactivac/index.aspx